Literature DB >> 25326276

Invasive Propionibacterium acnes infections in a non-selective patient cohort: clinical manifestations, management and outcome.

M Tebruegge1, C Jones, H de Graaf, P Sukhtankar, R N Allan, R P Howlin, D Browning, H Schuster, A Pallett, S Patel, S N Faust.   

Abstract

An increasing number of reports suggest that Propionibacterium acnes can cause serious invasive infections. Currently, only limited data exist regarding the spectrum of invasive P. acnes infections. We conducted a non-selective cohort study at a tertiary hospital in the UK over a 9-year-period (2003-2012) investigating clinical manifestations, risk factors, management, and outcome of invasive P. acnes infections. Forty-nine cases were identified; the majority were neurosurgical infections and orthopaedic infections (n = 28 and n = 15 respectively). Only 2 cases had no predisposing factors; all neurosurgical and 93.3 % of orthopaedic cases had a history of previous surgery and/or trauma. Foreign material was in situ at the infection site in 59.3 % and 80.0 % of neurosurgical and orthopaedic cases respectively. All neurosurgical and orthopaedic cases required one or more surgical interventions to treat P. acnes infection, with or without concomitant antibiotic therapy; the duration of antibiotic therapy was significantly longer in the group of orthopaedic cases (median 53 vs 19 days; p = 0.0025). All tested P. acnes isolates were susceptible to penicillin, ampicillin and chloramphenicol; only 1 was clindamycin-resistant. Neurosurgical and orthopaedic infections account for the majority of invasive P. acnes infections. Most cases have predisposing factors, including previous surgery and/or trauma; spontaneous infections are rare. Foreign material is commonly present at the site of infection, indicating that the pathogenesis of invasive P. acnes infections likely involves biofilm formation. Since invasive P. acnes infections are associated with considerable morbidity, further studies are needed to establish effective prevention and optimal treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25326276     DOI: 10.1007/s10096-014-2256-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  34 in total

1.  Reinfection rates after 1-stage revision shoulder arthroplasty for patients with unexpected positive intraoperative cultures.

Authors:  Matthew J Grosso; Vani J Sabesan; Jason C Ho; Eric T Ricchetti; Joseph P Iannotti
Journal:  J Shoulder Elbow Surg       Date:  2012-02-03       Impact factor: 3.019

2.  How to interpret a CSF--the art and the science.

Authors:  Tom Connell; Nigel Curtis
Journal:  Adv Exp Med Biol       Date:  2005       Impact factor: 2.622

3.  The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.

Authors:  S Nishijima; I Kurokawa; N Katoh; K Watanabe
Journal:  J Dermatol       Date:  2000-05       Impact factor: 4.005

4.  Role of rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model.

Authors:  Ulrika Furustrand Tafin; Stéphane Corvec; Bertrand Betrisey; Werner Zimmerli; Andrej Trampuz
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

5.  Propionibacterium acnes: an under-appreciated cause of post-neurosurgical infection.

Authors:  M Nisbet; S Briggs; R Ellis-Pegler; M Thomas; D Holland
Journal:  J Antimicrob Chemother       Date:  2007-09-17       Impact factor: 5.790

6.  Bacteriology of chronic otitis media, chronic sinusitis, and paranasal mucopyocele in Japan.

Authors:  K Ito; Y Ito; K Mizuta; H Ogawa; T Suzuki; H Miyata; N Kato; K Watanabe; K Ueno
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

Review 7.  Spondylodiscitis due to Propionibacterium acnes: report of twenty-nine cases and a review of the literature.

Authors:  I Uçkay; A Dinh; L Vauthey; N Asseray; N Passuti; M Rottman; J Biziragusenyuka; A Riché; P Rohner; D Wendling; S Mammou; R Stern; P Hoffmeyer; L Bernard
Journal:  Clin Microbiol Infect       Date:  2009-06-06       Impact factor: 8.067

8.  Significance of Propionibacterium acnes-positive samples in spinal instrumentation.

Authors:  Pascale Bémer; S Corvec; S Tariel; N Asseray; D Boutoille; C Langlois; B Tequi; H Drugeon; N Passuti; S Touchais
Journal:  Spine (Phila Pa 1976)       Date:  2008-12-15       Impact factor: 3.468

9.  Cerebrospinal fluid shunt infections in children over a 13-year period: anaerobic cultures and comparison of clinical signs of infection with Propionibacterium acnes and with other bacteria.

Authors:  Kai Arnell; Kristina Cesarini; Angela Lagerqvist-Widh; Tomas Wester; Jan Sjölin
Journal:  J Neurosurg Pediatr       Date:  2008-05       Impact factor: 2.375

10.  Formation of Propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials.

Authors:  Gordon Ramage; Michael M Tunney; Sheila Patrick; Sean P Gorman; James R Nixon
Journal:  Biomaterials       Date:  2003-08       Impact factor: 12.479

View more
  4 in total

Review 1.  The role of Cutibacterium acnes in auto-inflammatory bone disorders.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Eur J Pediatr       Date:  2018-10-15       Impact factor: 3.183

2.  De novo Propionibacterium acnes septic arthritis.

Authors:  Thomas Crowhurst; Joanna Tieu; Shaun Fowler; Simon Burnet
Journal:  BMJ Case Rep       Date:  2016-09-26

3.  Calcium sulphate mixed with antibiotics does not decrease efficacy against Cutibacterium acnes (formerly Propionibacterium acnes), in vitro study.

Authors:  Anne Couture; Valéry Lavergne; Emilie Sandman; Jean-Michel Leduc; Benoit Benoit; Stéphane Leduc; Dominique M Rouleau
Journal:  J Orthop       Date:  2019-11-28

4.  Recurrent strokes in an occult case of recurrent Cutibacterium acnes prosthetic valve infective endocarditis: a case report.

Authors:  Charles Fry; Christopher P Primus; Robert Serafino-Wani; Simon Woldman
Journal:  Eur Heart J Case Rep       Date:  2021-05-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.